AR058811A1 - Compuesto de hapteno y anticuerpo - Google Patents

Compuesto de hapteno y anticuerpo

Info

Publication number
AR058811A1
AR058811A1 ARP060104380A ARP060104380A AR058811A1 AR 058811 A1 AR058811 A1 AR 058811A1 AR P060104380 A ARP060104380 A AR P060104380A AR P060104380 A ARP060104380 A AR P060104380A AR 058811 A1 AR058811 A1 AR 058811A1
Authority
AR
Argentina
Prior art keywords
antibody
hapten
compound
bsh
antibody compound
Prior art date
Application number
ARP060104380A
Other languages
English (en)
Inventor
Mitsunori Kirihata
Tomoyuki Asano
Kohki Uehara
Original Assignee
Japan Science & Tech Agency
Univ Osaka Prefecture
Stella Chemifa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency, Univ Osaka Prefecture, Stella Chemifa Corp filed Critical Japan Science & Tech Agency
Publication of AR058811A1 publication Critical patent/AR058811A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un compuesto que tienen una estructura representada por la siguiente formula (1) y un anticuerpo para BSH obtenido utilizando el compuesto como un hapteno y un compuesto de alto peso molecular como un antígeno, un compuesto hapteno para preparar un anticuerpo que reconoce BSH con elevada sensibilidad y elevada selectividad, un anticuerpo a BSH, así como un kit para medir BSH y un método de medicion inmunologica, que utiliza el anticuerpo.
ARP060104380A 2006-02-23 2006-10-05 Compuesto de hapteno y anticuerpo AR058811A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006046950 2006-02-23

Publications (1)

Publication Number Publication Date
AR058811A1 true AR058811A1 (es) 2008-02-27

Family

ID=38437121

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104380A AR058811A1 (es) 2006-02-23 2006-10-05 Compuesto de hapteno y anticuerpo

Country Status (8)

Country Link
US (1) US8865874B2 (es)
EP (1) EP1988094B1 (es)
JP (1) JP4057046B2 (es)
KR (2) KR101159011B1 (es)
CN (1) CN101395162A (es)
AR (1) AR058811A1 (es)
AU (1) AU2006338844B2 (es)
WO (1) WO2007097065A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101159011B1 (ko) 2006-02-23 2012-06-21 스텔라 케미파 가부시키가이샤 햅텐 화합물 및 항체
JP2008203195A (ja) * 2007-02-22 2008-09-04 Japan Science & Technology Agency Ｂｓｈの免疫測定用キットおよびｂｓｈの測定方法
JP6360113B2 (ja) * 2016-07-28 2018-07-18 ステラファーマ株式会社 ホウ素含有化合物
CN116874515A (zh) * 2023-05-10 2023-10-13 重庆高硼生物科技有限公司 一种氨基酸-bsh靶向杂合体化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533493A (en) * 1981-08-27 1985-08-06 Miles Laboratories, Inc. Theophylline immunogens, antibodies, labeled conjugates, and related derivatives
JPH02207086A (ja) 1989-02-03 1990-08-16 Shionogi & Co Ltd カゴ型ホウ素化合物、そのタンパク質との複合体およびその製造方法
US6228362B1 (en) * 1992-08-21 2001-05-08 Immunomedics, Inc. Boron neutron capture therapy using pre-targeting methods
JPH07330773A (ja) 1994-06-07 1995-12-19 Toyo Hatsuka Kogyo Kk ポルフィリン誘導体とその用途
JP2001233883A (ja) 2000-02-22 2001-08-28 Okayama Pref Gov Shin Gijutsu Shinko Zaidan カゴ状ホウ素化合物担持ポルフィリン錯体
EP1321466B1 (en) * 2001-12-20 2011-01-26 Randox Laboratories Ltd. Haptens, immunogens, antibodies and conjugates for 2-oxo-3-hydroxy LSD
KR101159011B1 (ko) 2006-02-23 2012-06-21 스텔라 케미파 가부시키가이샤 햅텐 화합물 및 항체

Also Published As

Publication number Publication date
AU2006338844B2 (en) 2010-07-08
KR20100110898A (ko) 2010-10-13
AU2006338844A1 (en) 2007-08-30
US20090317920A1 (en) 2009-12-24
KR20080112246A (ko) 2008-12-24
JP4057046B2 (ja) 2008-03-05
KR101159011B1 (ko) 2012-06-21
EP1988094A4 (en) 2010-10-27
EP1988094A1 (en) 2008-11-05
KR100998419B1 (ko) 2010-12-03
CN101395162A (zh) 2009-03-25
EP1988094B1 (en) 2014-06-11
US8865874B2 (en) 2014-10-21
JPWO2007097065A1 (ja) 2009-07-09
WO2007097065A1 (ja) 2007-08-30

Similar Documents

Publication Publication Date Title
ES2487846T3 (es) Anticuerpos anti-hepcindina y métodos de uso
CY1121536T1 (el) Ανθρωπινα αντισωματα εναντι-αλφα-συνουκλεϊνης
GT200500298A (es) Formulaciones de anticuerpos
BRPI0607323B8 (pt) composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
CL2008003782A1 (es) Anticuerpo bivalente bioespecifico que comprende la cadena ligera y pesada de un anticuerpo que se une a un primer antigeno donde el dominio ch3 se reemplaza por ch1, y la cadena ligera y pesada de un anticuerpo que se une a un segundo antigeno, en el que el dominio ch3 esta reemplazado por cl; metodo de preparacion; y composicion.
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
CY1115848T1 (el) 1-αρυλο-3-αμινοαλκοξυ πυραζολες ως προσδετες σιγμα για την ενισχυση της αναλγητικης επιδρασης των οπιοειδων και την εξασθενηση της εξαρτησης απο αυτα
DE602006006200D1 (de) Antikörper gegen 25-hydroxyvitamin d
TR201901841T4 (tr) Her antikorlarının sabit dozlaması.
CR20110035A (es) Composiciones y Métodos para Anticuerpos que se dirigen a la Proteína de Complemento C5
AR054474A1 (es) Formulacion de anticuerpos estables
HN2006015949A (es) Anticuerpos de p-caderina
CO6280567A2 (es) Establecimiento de un anticuerpo monoclonal para detector de proteinas pag en la circulacion
AR082630A1 (es) Anticuerpos anti-tenascina-c a2 y metodos de uso
DK1794586T3 (da) Monoklonale antistoffer til progastrin
AR069775A1 (es) Anticuerpos bivalentes biespecificos
NL2002255A1 (nl) Antilichamen tegen myostatine.
CR20110544A (es) Anticuerpo antagonista específico para el heterodímero de alfa-4-beta-7
WO2006086208A3 (en) 5-fluoro-uracil immunoassay
CR20110559A (es) Anticuerpos específicos para cadherina-17
CY1111811T1 (el) Μεθοδοι ms για την αξιολογηση γλυκανων
ECSP12012317A (es) Marcadores predictivos útiles en el tratamiento del síndrome frágil x (fxs)
BRPI0814250B8 (pt) dispositivo, kit e método para captura e detecção de antígeno de ancilóstomo
FI20075251A0 (fi) Immunomääritys epästabiilien antigeenien määrittämiseksi
AR058811A1 (es) Compuesto de hapteno y anticuerpo

Legal Events

Date Code Title Description
FG Grant, registration